[1] 曹楠珏. 单纯疱疹性角膜炎发病机制的研究进展[J]. 中华实验眼科杂志,2017,35(2):175-179. DOI:10.3760/cma.j.issn.2095-0160.2017.02.017.
[2] 齐瑞荣. 玻璃体腔雷珠单抗注射联合激光治疗对糖尿病视网膜病变患者术后视网膜厚度及并发症发生率的影响[J]. 国际医药卫生导报,2018,24(8):1189-1192. DOI:10.3760/cma.j.issn.1007-1245.2018.08.018.
[3] Lamm V, Hara H, Mammen A, et al. Corneal blindness and xenotransplantation[J].Xenotransplantation,2014,21(2):99-114. DOI:10.1111/xen.12082.
[4] 杜园园,王跃,吴宏. 抗生素滴眼剂致药物毒性眼表损害分析[J]. 中国实验诊断学,2008,12(9):1166-1167. DOI:10.3969/j.issn.1007-4287.2008.09.038.
[5] Nicoară SD, Damian I. Controversy of indomethacin eye drops in the treatment of rheumatoid arthritis-induced corneal ulceration: a case report[J].J Med Case Rep,2021,15(1):116. DOI:10.1186/s13256-020-02600-9.
[6] 王燕,陈华洁,朱力,等. 不规范的药物应用对眼表组织损害的临床分析[J]. 国际眼科杂志,2015,15(10):1830-1832. DOI:10.3980/j.issn.1672-5123.2015.10.46.
[7] Holland EJ, Luchs J, Karpecki PM, et al. Lifitegrast for the treatment of dry eye disease: results of a phase III, randomized, double-masked, placebo-controlled trial (OPUS-3)[J].Ophthalmology,2017,124(1):53-60. DOI:10.1016/j.ophtha.2016.09.025.
[8] 钱满连,吴秀萍,全宇莉,等. 眼病患者滴眼液知识掌握情况调查[J]. 护理学报,2009,16(4):13-14. DOI:10.3969/j.issn.1008-9969.2009.04.005.
[9] 黄少燕,吴柳萍,陈烨. 汕头市公众眼药水认知情况及使用行为调查分析[J]. 中国医院药学杂志,2016,36(13):1128-1132,1043. DOI:10.13286/j.cnki.chinhosppharmacyj.2016.13.22.
[10] 霍敏,张静,董玉红. 妥布霉素滴眼液治疗重症细菌感染性角膜炎的疗效及炎症因子、T淋巴细胞亚群变化[J]. 贵州医药,2021,45(9):1409-1410. DOI:10.3969/j.issn.1000- 744X.2021.09.031.
[11] 黄丽萍,王芬,郑玲. 一起医院内结膜炎暴发的调查与控制[J]. 中国消毒学杂志,2017,34(3):294-296. DOI:10.11726/j.issn.1001-7658.2017.03.036.
[12] 蘧荣荣,叶成富. 失效模式和效应分析在眼科医院医护人员手卫生依从性的应用[J]. 中华劳动卫生职业病杂志,2018,36(6):448-451. DOI:10.3760/cma.j.issn.1001-9391.2018. 06.014.
[13] Boadi-Kusi SB, Kyei S, Ocansey S, et al. Assessment of infection prevention and control measures adopted by eye care practitioners in Ghana and South Africa against COVID-19[J].Sci Afr,2021,12:e00766. DOI:10.1016/j.sciaf. 2021.e00766.
[14] Awwad S, Mohamed Ahmed AHA, Sharma G, et al. Principles of pharmacology in the eye[J].Br J Pharmacol,2017,174(23):4205-4223. DOI:10.1111/bph.14024.
[15] Yazu H, Fukagawa K, Shimizu E, et al. Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases[J].Allergy Asthma Clin Immunol,2021,17(1):11. DOI:10.1186/s13223-021- 00513-w.
[16] Tsegaw A, Tsegaw A, Abula T, et al. Bacterial contamination of multi-dose eye drops at ophthalmology department, University of Gondar, Northwest Ethiopia[J].Middle East Afr J Ophthalmol,2017,24(2):81-86. DOI:10.4103/meajo.MEAJO_308_16.
[17] Sanchez FG, Mansberger SL, Kung Y, et al. Novel eye drop delivery aid improves outcomes and satisfaction[J].Ophthalmol Glaucoma,2021,4(5):440-446. DOI:10.1016/j.ogla.2021.01.001.
[18] Kang YK, Im JC, Shin JP, et al. Short-term analysis of the residual volume of an eye drop following 23-gauge microincision vitrectomy surgery[J].Korean J Ophthalmol,2017,31(5):439-445. DOI:10.3341/kjo.2016.0090.
[19] Cagini C, Torroni G, Mariniello M, et al. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders[J].Int Ophthalmol,2021,41(9):3065-3071. DOI:10.1007/s10792-021-01869-z.
[20] Pan Q, Angelina A, Marrone M, et al. Autologous serum eye drops for dry eye[J].Cochrane Database Syst Rev,2017,2(2):CD009327. DOI:10.1002/14651858.CD009327.pub3.
[21] 刘海波,孙玲,马月仙. 眼药水间隔时间对急性结膜炎患者疗效的影响[J]. 护士进修杂志,2014,29(7):662-663. DOI:10.16821/j.cnki.hsjx.2014.07.039.
[22] Reda A, Van Schepdael A, Adams E, et al. Effect of storage conditions on stability of ophthalmological compounded cysteamine eye drops[J].JIMD Rep,2018,42:47-51. DOI:10.1007/8904_2017_77.
[23] 李怡,王欣. 不同环境下滴眼液污染情况比较[J]. 护理研究,2016,30(24):3054-3055. DOI:10.3969/j.issn.1009-6493. 2016.24.038.
[24] 陈玉红,何莲,刘作颖. 重组人表皮生长因子凝胶联合玻璃酸钠滴眼液治疗对白内障超声乳化术后干眼症患者泪膜稳定性、泪液基础分泌量的影响[J]. 实用医院临床杂志,2021,18(1):162-165. DOI:10.3969/j.issn.1672-6170. 2021.01.046.
[25] Yuksel N, Akcay E, Kilicarslan A, et al. A surprise in the lacrimal sac[J].Middle East Afr J Ophthalmol,2016,23(3):268-270. DOI:10.4103/0974-9233.180777.
|